Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvaf248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Dennis Mehrkens und 51 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Marfan Syndrome, Peroxidase, Aortic Aneurysm, Thoracic, Vascular Remodeling. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Center for Molecular Medicine Cologne, Neven-DuMont Foundation.
Abstract (Originalsprache)
Aims
Patients suffering from Marfan syndrome (MFS), the most prevalent inherited connective tissue disorder, face premature mortality due to dissection and rupture of thoracic aortic aneurysms. Here, we questioned whether myeloperoxidase (MPO), a leucocyte-derived enzyme with high affinity to the vessel wall, contributes to aortic remodelling in MFS. Methods and results Plasma MPO levels were evaluated in MFS patients and healthy controls. Thoracic aortic aneurysm formation was determined in heterozygous transgenic Fbn1C1041G/+ (MFS) mice, MPO-deficient MFS mice (MFSxMpo−/−), and MFS mice treated with an MPO inhibitor by ultrasound and histology. MFS patients exhibited increased circulating MPO levels and marked aortic MPO deposition. In MFS mice, MPO-deficiency reduced aortic elastin fragmentation and aneurysm formation. RNA sequencing revealed an inflammatory gene program in aortic endothelial cells isolated from MFS mice in comparison to WT and MFSxMpo−/− mice. This was accompanied by enhanced endothelial expression of the leucocyte adhesion molecule ICAM-1, increased leucocyte adhesion, and, consequently, leucocyte infiltration in MFS aortae. Moreover, MPO directly contributed to adverse extracellular matrix remodelling through overproduction of reactive oxygen species and subsequent vascular protein modifications leading to enhanced matrix metalloproteinase 2/9 activity. Lastly, treatment of MFS mice with the orally available MPO inhibitor AZM198 attenuated TAA formation.
Conclusion
MPO is increased in MFS and contributes to thoracic aortic dilatation by inducing inflammatory endothelial activation, oxidative stress, and adverse extracellular matrix remodelling. Pharmacological and genetic inhibition of MPO reduced MFS-related aortic dilation in mice, highlighting MPO as a promising therapeutic target in MFS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- Life and Brain Center, Medical Faculty, Institute of Physiology I, University of Bonn, Bonn, Germany.
- Gene Regulation in Cardiovascular Remodeling and Inflammation Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid 28029, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
- Department of Cardiology, Hospital Universitari Vall D'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
ORCID-Profile: Dennis Mehrkens, Alexander Hof, Henning Guthoff, Maarten Groenink, Ulrich Flögel, Matti Adam, Stephan Baldus, Martin Mollenhauer, Holger Winkels
Förderung
- Deutsche Forschungsgemeinschaft
- Center for Molecular Medicine Cologne
- Neven-DuMont Foundation
- La Caixa Banking Foundation
- Instituto de Salud Carlos III
Zitieren
APA
Mehrkens, D., Dohr, J., Nettersheim, F. S., Ballmann, F., Bastigkeit, J., Brückner, A., Geissen, S., De Vore, L., Fitsch, C., Diekmann, C., de la Fuente-Alonso, A., Schelemei, P., Picard, F. R., Kochen, M., Arkenberg, P., Rappenecker, A., Ahdab, M., Nemade, H., Narayan, S., …, & Winkels, H. (2026). Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf248
Vancouver
Mehrkens D, Dohr J, Nettersheim FS, Ballmann F, Bastigkeit J, Brückner A, et al. Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease. Cardiovascular Research. 2026. doi:10.1093/cvr/cvaf248
BibTeX
@article{Mehrkens2026,
author = {Mehrkens, Dennis and Dohr, Johannes and Nettersheim, Felix Sebastian and Ballmann, Felix and Bastigkeit, Jil and Brückner, Alexander and Geissen, Simon and De Vore, Lauren and Fitsch, Cedric and Diekmann, Chris and de la Fuente-Alonso, Andrea and Schelemei, Patrik and Picard, Felix Ruben and Kochen, Malte and Arkenberg, Per and Rappenecker, Anna and Ahdab, Maysam and Nemade, Harshal and Narayan, Suchitra and Braumann, Simon and Kreuzberg, Wiebke and Hof, Alexander and Guthoff, Henning and Mensah, Benedicta Quaye and Lechner, Sebastian and Guala, Andrea and Evangelista, Artur and Teixido-Tura, Gisela and Nistal, J Francisco and Campanero, Miguel R and Kaemmerer, Harald and Wolf, Zsuzsanna and Holdenrieder, Stefan and Groenink, Maarten and van Andel, Mitzi and Mieremet, Arnout and Pfeiler, Susanne and Gerdes, Norbert and Flögel, Ulrich and Zimmermann, Laura-Maria and Sengle, Gerhard and Eich, Marie-Lisa and Schömig-Markiefka, Birgid and Adam, Matti and Fleischmann, Bernd K and Wenzel, Daniela and Redondo, Juan Miguel and de Waard, Vivian and Klinke, Anna and Baldus, Stephan and Mollenhauer, Martin and Winkels, Holger},
title = {Myeloperoxidase aggravates thoracic aortic aneurysm formation in Marfan disease},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvaf248}
}
EUVIMED